News from sutro biopharma

Mar 24, 2014, 09:00 ET

Sutro Biopharma to Present at 21st Annual Future Leaders in the Biotech Industry Conference

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug...

Jan 07, 2014, 09:00 ET

Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug...

Dec 11, 2013, 09:00 ET

Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products

Sutro Biopharma today announced that the company has secured $26 million in a Series D financing. The additional financing will fund the expansion...

Oct 15, 2013, 14:00 ET

Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit

 Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...

Jan 31, 2013, 09:00 ET

Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...

Jan 03, 2013, 09:00 ET

Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates

Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro's cell-free protein synthesis...

Oct 24, 2012, 09:00 ET

Sutro Biopharma Expands Senior Management Team

 Sutro Biopharma, a biopharmaceutical company developing a new generation of antibody drug conjugate therapeutics and bifunctional...

Jun 14, 2012, 09:00 ET

Sutro Licenses "Click Chemistry" from The Scripps Research Institute

 Sutro Biopharma today announced that it has signed a licensing agreement with The Scripps Research Institute and will have access to "click...

May 08, 2012, 07:30 ET

Sutro Closes $16.5 Million Second Tranche of Series C Financing

 Sutro Biopharma today announced the closing of the $16.5 million second tranche of its Series C financing. This financing was led by Skyline...

Jan 07, 2012, 09:00 ET

Sutro Announces Newly Formed Scientific Advisory Board

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties,...

Oct 17, 2011, 09:00 ET

Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...

May 19, 2011, 09:00 ET

Study Shows Sutro Biopharma's Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...

Jan 07, 2011, 09:00 ET

Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics

Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today...

Dec 08, 2010, 09:00 ET

Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer

Sutro Biopharma, a biopharmaceutical company developing both novel and biosuperior protein therapeutics with improved pharmaceutical properties,...

Nov 17, 2010, 09:00 ET

Sutro Biopharma Secures $36.5 Million in Series C Financing

Sutro Biopharma today announced that the company has secured $36.5 million in Series C financing. This financing will support the company's ongoing...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer